shapiro

The Pennsylvania Medical Cannabis Society (PAMCS) and its members would like to applaud the Pennsylvania Medical Society (PAMED) for their recent statement calling upon the FDA to reclassify cannabis as a Schedule II rather than Schedule I drug to facilitate further research. While this is an...